Sign In
Buy ATNM
$0.84
-0.0001 (-0.0119%)
At Close: Jul 31, 2026
Hedge Funds Cautiously Watching Actinium Pharmaceuticals Inc (ATNM)
01:45am, Friday, 05'th Jun 2020
In this article we will take a look at whether hedge funds think Actinium Pharmaceuticals Inc (NYSE:ATNM) is a good investment right now. We check hedge fund and billionaire investor sentiment before
Benzinga's Top Upgrades, Downgrades For June 4, 2020
01:42pm, Thursday, 04'th Jun 2020
Upgrades * For American Eagle Outfitters Inc (NYSE: AEO), Morgan Stanley upgraded the stock from Underweight to Equal-Weight. For the first quarter, American Eagle Outfitters had an EPS of ($0.84),
H.C. Wainwright Initiates Coverage On Actinium Pharmaceuticals with Buy Rating, Announces Price Target of $3
10:38am, Thursday, 04'th Jun 20203 “Strong Buy” Healthcare Stocks Under $5 With Big Upside Potential
01:53pm, Wednesday, 03'rd Jun 2020
A sense of cautious optimism is looming over the Street given the progress in the reopening of the U.S. economy, and while the recent uptick isn’t necessarily indicative of a full recovery, it’s c
Viking Therapeutics (VKTX) Received its Third Buy in a Row
11:32am, Saturday, 02'nd May 2020
After Stifel Nicolaus and H.C. Wainwright gave Viking Therapeutics (NASDAQ: VKTX) a Buy rating last month, the company received another
BioCardia (BCDA) Gets a Buy Rating from Maxim Group
04:56pm, Friday, 01'st May 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to BioCardia (BCDA), with a price target of $9.00. The company's shares
BioCardia (BCDA) Gets a Buy Rating from Maxim Group
04:56pm, Friday, 01'st May 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to BioCardia (BCDA – Research Report),
Sabby Management Llc Reports 7.29% Passive Stake in Actinium Pharmaceuticals as of April 22
12:47pm, Friday, 01'st May 2020Maxim Group Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)
11:47am, Friday, 01'st May 2020
Maxim Group analyst Jason McCarthy maintained a Hold rating on Vertex Pharmaceuticals (VRTX) today. The company's shares closed last Thursday at $251.20.
Maxim Group Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)
11:47am, Friday, 01'st May 2020
Maxim Group analyst Jason McCarthy maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today. The company’s shares
Maxim Group Gives a Hold Rating to Gilead Sciences (GILD)
05:12pm, Thursday, 30'th Apr 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Hold rating to Gilead Sciences (GILD). The company's shares closed last Thursday at
Maxim Group Gives a Hold Rating to Gilead Sciences (GILD)
05:12pm, Thursday, 30'th Apr 2020
In a report released today,
Jason McCarthy
from Maxim Group assigned a
Hold
rating to Gilead Sciences (
GILD
–
Research Report
). The company’s shares closed last Thursday at $81.90, close to its
